117 results on '"Regnér, S."'
Search Results
2. Monocyte Chemoattractant Protein 1, Active Carboxypeptidase B and CAPAP at Hospital Admission Are Predictive Markers for Severe Acute Pancreatitis
- Author
-
Régner, S., Appelros, S., Hjalmarsson, C., Manjer, J., Sadic, J., and Borgström, A.
- Published
- 2008
- Full Text
- View/download PDF
3. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition
- Author
-
Jeurnink, S. M., Büchner, F. L., Bueno-de-Mesquita, H. B., Siersema, P. D., Boshuizen, H. C., Numans, M. E., Dahm, C. C., Overvad, K., Tjnneland, A., Roswall, N., Clavel-Chapelon, F., Boutron-Ruault, M. C., Morois, S., Kaaks, R., Teucher, B., Boeing, H., Buijsse, B., Trichopoulou, A., Benetou, V., Zylis, D., Palli, D., Sieri, S., Vineis, P., Tumino, R., Panico, S., Ocké, M. C., Peeters, P. H.M., Skeie, G., Brustad, M., Lund, E., Sánchez-Cantalejo, E., Navarro, C., Amiano, P., Ardanaz, E., Ramón Quirós, J., Hallmans, G., Johansson, I., Lindkvist, B., Regnér, S., Khaw, K. T., Wareham, N., Key, T. J., Slimani, N., Norat, T., Vergnaud, A. C., Romaguera, D., and Gonzalez, C. A.
- Published
- 2012
- Full Text
- View/download PDF
4. P–selectin mediates neutrophil rolling and recruitment in acute pancreatitis
- Author
-
Hartman, H., Abdulla, A., Awla, D., Lindkvist, B., Jeppsson, B., Thorlacius, H., and Regnér, S.
- Published
- 2012
- Full Text
- View/download PDF
5. Rho-kinase signalling regulates trypsinogen activation and tissue damage in severe acute pancreatitis
- Author
-
Awla, D, Hartman, H, Abdulla, A, Zhang, S, Rahman, M, Regnér, S, and Thorlacius, H
- Published
- 2011
- Full Text
- View/download PDF
6. Role of platelets in experimental acute pancreatitis
- Author
-
Abdulla, A., Awla, D., Hartman, H., Rahman, M., Jeppsson, B., Regnér, S., and Thorlacius, H.
- Published
- 2011
7. Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Author
-
Sanikini, H., Sophiea, M., Rinaldi, S., Agudo, A., Duell, E.J., Weiderpass, E., Overvad, K., Tjønneland, A., Halkjær, J., Boutron-Ruault, M.-C., Carbonnel, F., Cervenka, I., Boeing, H., Kaaks, R., Kühn, T., Trichopoulou, A., Martimianaki, G., Karakatsani, A., Pala, V., Palli, D., Mattiello, A., Tumino, R., Sacerdote, C., Skeie, G., Rylander, C., Chirlaque López, M.-D., Sánchez, M.-J., Ardanaz, E., Regnér, S., Stocks, T., Bueno-de-Mesquita, B., Vermeulen, R.C.H., Aune, D., Tong, T.Y.N., Kliemann, N., Murphy, N., Chadeau-Hyam, M., Gunter, M.J., Cross, A.J., IRAS OH Epidemiology Chemical Agents, and dIRAS RA-2
- Subjects
reproductive ,obesity ,hormones ,esophageal ,cancer ,gastric - Abstract
Obesity has been associated with upper gastrointestinal cancers; however, there are limited prospective data on associations by subtype/subsite. Obesity can impact hormonal factors, which have been hypothesized to play a role in these cancers. We investigated anthropometric and reproductive factors in relation to esophageal and gastric cancer by subtype and subsite for 476,160 participants from the European Prospective Investigation into Cancer and Nutrition cohort. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox models. During a mean follow-up of 14 years, 220 esophageal adenocarcinomas (EA), 195 esophageal squamous cell carcinomas, 243 gastric cardia (GC) and 373 gastric noncardia (GNC) cancers were diagnosed. Body mass index (BMI) was associated with EA in men (BMI ≥30 vs. 18.5–25 kg/m2: HR = 1.94, 95% CI: 1.25–3.03) and women (HR = 2.66, 95% CI: 1.15–6.19); however, adjustment for waist-to-hip ratio (WHR) attenuated these associations. After mutual adjustment for BMI and HC, respectively, WHR and waist circumference (WC) were associated with EA in men (HR = 3.47, 95% CI: 1.99–6.06 for WHR >0.96 vs. 98 vs. 0.82 vs. 84 vs. 2 vs. 0) and age at first pregnancy and GNC (HR = 0.54, 95% CI: 0.32–0.91; >26 vs.
- Published
- 2020
8. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study
- Author
-
Naudin, S. Viallon, V. Hashim, D. Freisling, H. Jenab, M. Weiderpass, E. Perrier, F. McKenzie, F. Bueno-de-Mesquita, H.B. Olsen, A. Tjønneland, A. Dahm, C.C. Overvad, K. Mancini, F.R. Rebours, V. Boutron-Ruault, M.-C. Katzke, V. Kaaks, R. Bergmann, M. Boeing, H. Peppa, E. Karakatsani, A. Trichopoulou, A. Pala, V. Masala, G. Panico, S. Tumino, R. Sacerdote, C. May, A.M. van Gils, C.H. Rylander, C. Borch, K.B. Chirlaque López, M.D. Sánchez, M.-J. Ardanaz, E. Quirós, J.R. Amiano Exezarreta, P. Sund, M. Drake, I. Regnér, S. Travis, R.C. Wareham, N. Aune, D. Riboli, E. Gunter, M.J. Duell, E.J. Brennan, P. Ferrari, P.
- Abstract
Pancreatic cancer (PC) is a highly fatal cancer with currently limited opportunities for early detection and effective treatment. Modifiable factors may offer pathways for primary prevention. In this study, the association between the Healthy Lifestyle Index (HLI) and PC risk was examined. Within the European Prospective Investigation into Cancer and Nutrition cohort, 1113 incident PC (57% women) were diagnosed from 400,577 participants followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary exposure, physical activity and, in turn, overall and central adiposity using BMI (HLIBMI) and waist-to-hip ratio (WHR, HLIWHR), respectively. High values of HLI indicate adherence to healthy behaviors. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and 95% confidence intervals (CI). Sensitivity analyses were performed by excluding, in turn, each factor from the HLI score. Population attributable fractions (PAF) were estimated assuming participants’ shift to healthier lifestyles. The HRs for a one-standard deviation increment of HLIBMI and HLIWHR were 0.84 (95% CI: 0.79, 0.89; ptrend = 4.3e−09) and 0.77 (0.72, 0.82; ptrend = 1.7e−15), respectively. Exclusions of smoking from HLIWHR resulted in HRs of 0.88 (0.82, 0.94; ptrend = 4.9e−04). The overall PAF estimate was 19% (95% CI: 11%, 26%), and 14% (6%, 21%) when smoking was removed from the score. Adherence to a healthy lifestyle was inversely associated with PC risk, beyond the beneficial role of smoking avoidance. Public health measures targeting compliance with healthy lifestyles may have an impact on PC incidence. © 2019, Springer Nature B.V.
- Published
- 2020
9. Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Author
-
Sanikini, H. Muller, D.C. Sophiea, M. Rinaldi, S. Agudo, A. Duell, E.J. Weiderpass, E. Overvad, K. Tjønneland, A. Halkjær, J. Boutron-Ruault, M.-C. Carbonnel, F. Cervenka, I. Boeing, H. Kaaks, R. Kühn, T. Trichopoulou, A. Martimianaki, G. Karakatsani, A. Pala, V. Palli, D. Mattiello, A. Tumino, R. Sacerdote, C. Skeie, G. Rylander, C. Chirlaque López, M.-D. Sánchez, M.-J. Ardanaz, E. Regnér, S. Stocks, T. Bueno-de-Mesquita, B. Vermeulen, R.C.H. Aune, D. Tong, T.Y.N. Kliemann, N. Murphy, N. Chadeau-Hyam, M. Gunter, M.J. Cross, A.J.
- Abstract
Obesity has been associated with upper gastrointestinal cancers; however, there are limited prospective data on associations by subtype/subsite. Obesity can impact hormonal factors, which have been hypothesized to play a role in these cancers. We investigated anthropometric and reproductive factors in relation to esophageal and gastric cancer by subtype and subsite for 476,160 participants from the European Prospective Investigation into Cancer and Nutrition cohort. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox models. During a mean follow-up of 14 years, 220 esophageal adenocarcinomas (EA), 195 esophageal squamous cell carcinomas, 243 gastric cardia (GC) and 373 gastric noncardia (GNC) cancers were diagnosed. Body mass index (BMI) was associated with EA in men (BMI ≥30 vs. 18.5–25 kg/m2: HR = 1.94, 95% CI: 1.25–3.03) and women (HR = 2.66, 95% CI: 1.15–6.19); however, adjustment for waist-to-hip ratio (WHR) attenuated these associations. After mutual adjustment for BMI and HC, respectively, WHR and waist circumference (WC) were associated with EA in men (HR = 3.47, 95% CI: 1.99–6.06 for WHR >0.96 vs. 98 vs. 0.82 vs. 84 vs. 2 vs. 0) and age at first pregnancy and GNC (HR = 0.54, 95% CI: 0.32–0.91; >26 vs.
- Published
- 2020
10. Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Author
-
IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Sanikini, H., Sophiea, M., Rinaldi, S., Agudo, A., Duell, E.J., Weiderpass, E., Overvad, K., Tjønneland, A., Halkjær, J., Boutron-Ruault, M.-C., Carbonnel, F., Cervenka, I., Boeing, H., Kaaks, R., Kühn, T., Trichopoulou, A., Martimianaki, G., Karakatsani, A., Pala, V., Palli, D., Mattiello, A., Tumino, R., Sacerdote, C., Skeie, G., Rylander, C., Chirlaque López, M.-D., Sánchez, M.-J., Ardanaz, E., Regnér, S., Stocks, T., Bueno-de-Mesquita, B., Vermeulen, R.C.H., Aune, D., Tong, T.Y.N., Kliemann, N., Murphy, N., Chadeau-Hyam, M., Gunter, M.J., Cross, A.J., IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Sanikini, H., Sophiea, M., Rinaldi, S., Agudo, A., Duell, E.J., Weiderpass, E., Overvad, K., Tjønneland, A., Halkjær, J., Boutron-Ruault, M.-C., Carbonnel, F., Cervenka, I., Boeing, H., Kaaks, R., Kühn, T., Trichopoulou, A., Martimianaki, G., Karakatsani, A., Pala, V., Palli, D., Mattiello, A., Tumino, R., Sacerdote, C., Skeie, G., Rylander, C., Chirlaque López, M.-D., Sánchez, M.-J., Ardanaz, E., Regnér, S., Stocks, T., Bueno-de-Mesquita, B., Vermeulen, R.C.H., Aune, D., Tong, T.Y.N., Kliemann, N., Murphy, N., Chadeau-Hyam, M., Gunter, M.J., and Cross, A.J.
- Published
- 2020
11. Endoscopic Papillectomy compared to Surgery for Non-Invasive Ampullary Lesions and early Ampullary Cancers - a Pancreas2000 / European Pancreatic Club - Study
- Author
-
Hollenbach, Marcus, Heise, C., Abou-Ali, E., Gulla, A., Auriemma, F., Regner, S., and Gaujoux, S.
- Published
- 2022
- Full Text
- View/download PDF
12. Surgical intervention for intestinal typhoid perforation
- Author
-
Nilsson, E., Olsson, S., Regnér, S., Polistena, A., mahamudu ayamba ali, Dedey, F., Avenia, N., Wu, L., and Johnson, L. B.
- Subjects
Male ,Young Adult ,Intestinal Perforation ,Humans ,Female ,Typhoid Fever ,Digestive System Surgical Procedures ,Retrospective Studies - Abstract
Typhoid perforation is the most fatal complication of typhoid fever in developing countries and is most often caused by the bacteria Salmonella Typhi. There are conflicting views as to which type of surgical intervention gives the best outcome. The aim of this study was to determine the mortality associated with the different types of surgical interventions employed in patients with typhoid perforation.This was a retrospective review of the medical records of adult and paediatric surgical patients treated in the general and paediatric surgical units of the Korle Bu Teaching Hospital. Information was obtained from medical records at the Korle Bu Teaching Hospital in Accra, Ghana, between January 2009 and April 2012. The data was analysed using IBM SPSS Statistics version 20 and 22.133 patients (median age of 21 years, 72.2% males) with typhoid perforation were included in the study. The typhoid perforation specific mortality rate was 12.8%. Males had a significantly lower mortality rate (7.3%) compared to females (27%). Simple bowel closure (85.7% of total) was the most common surgical intervention performed and patients operated upon with this method had a significantly lower mortality rate (9.6%) compared to patients with bowel resection (31.6%).In this study, patients treated with intestinal resection were more likely to die from typhoid perforation and female gender was a risk factor for death. Simple bowel closure was the predominant surgical procedure.
- Published
- 2019
13. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
- Author
-
Dominguez-Munoz, J.E., primary, Drewes, A.M., additional, Lindkvist, B., additional, Ewald, N., additional, Czakó, L., additional, Rosendahl, J., additional, Löhr, J.M., additional, Löhr, M., additional, Dominguez-Munoz, J.E., additional, Besselink, M., additional, Mayerle, J., additional, Lerch, M.M., additional, Akisik, F., additional, Kartalis, N., additional, Manfredi, R., additional, Iglesias-Garcia, J., additional, Haas, S.L., additional, Keller, J., additional, Boermeester, M.A., additional, Werner, J., additional, Dumonceau, J.M., additional, Fockens, P., additional, Drewes, A., additional, Cheyan, G.O., additional, Drenth, J.P., additional, Hardt, P., additional, de Madaria, E., additional, Gheorghe, C., additional, Lindgren, F., additional, Schneider, A., additional, Witt, H., additional, Bollen, T., additional, Boraschi, P., additional, Frøkjær, J.B., additional, Rudolf, S., additional, Bruno, M., additional, Dimcevski, G., additional, Giovannini, M., additional, Pukitis, A., additional, Petrone, M., additional, Oppong, K., additional, Ammori, B., additional, Friess, H., additional, Izbiki, J.R., additional, Ganeh, P., additional, Salvia, R., additional, Sauvanet, A., additional, Barbu, S., additional, Lyadov, V., additional, Deprez, P., additional, Gubergrits, N., additional, Okhlobystiy, A.V., additional, Arvanitakis, M., additional, Costamagna, G., additional, Pap, A., additional, Andersson, R., additional, Hauge, T., additional, McKay, C., additional, Regnér, S., additional, Dite, P., additional, Olesen, S.S., additional, Duggan, S., additional, Hopper, A., additional, Phillips, M., additional, Shvets, O., additional, Vujasinovic, M., additional, Czako, L., additional, Piemonti, L., additional, Kocher, H., additional, Rebours, V., additional, Stimac, D., additional, and Hegyi, P., additional
- Published
- 2020
- Full Text
- View/download PDF
14. Endoscopic papillectomy vs. pancreaticoduodenectomy for ampullary lesions: A propensity-scored matching analysis of the ESAP study
- Author
-
Hollenbach, M., Heise, C., Ali, E.A., Auriemma, F., Gulla, A., Regner, S., and Gaujoux, S.
- Published
- 2021
- Full Text
- View/download PDF
15. IL-6 and CRP are superior in early severity stratification of acute pancreatitis
- Author
-
Sternby, H., primary, Hartman, H., additional, Thorlacius, H., additional, and Regnér, S., additional
- Published
- 2019
- Full Text
- View/download PDF
16. Clinical features upon admission and outcomes of patients with acute pancreatitis – comparison between two European cohorts
- Author
-
Sternby, H., primary, Regnér, S., additional, and de Madaria, E., additional
- Published
- 2018
- Full Text
- View/download PDF
17. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study
- Author
-
Huang, J. Zagai, U. Hallmans, G. Nyrén, O. Engstrand, L. Stolzenberg-Solomon, R. Duell, E.J. Overvad, K. Katzke, V.A. Kaaks, R. Jenab, M. Park, J.Y. Murillo, R. Trichopoulou, A. Lagiou, P. Bamia, C. Bradbury, K.E. Riboli, E. Aune, D. Tsilidis, K.K. Capellá, G. Agudo, A. Krogh, V. Palli, D. Panico, S. Weiderpass, E. Tjønneland, A. Olsen, A. Martínez, B. Redondo-Sanchez, D. Chirlaque, M.-D. HM Peeters, P. Regnér, S. Lindkvist, B. Naccarati, A. Ardanaz, E. Larrañaga, N. Boutron-Ruault, M.-C. Rebours, V. Barré, A. Bueno-de-Mesquita, H.B. Ye, W.
- Abstract
The association between H. pylori infection and pancreatic cancer risk remains controversial. We conducted a nested case-control study with 448 pancreatic cancer cases and their individually matched control subjects, based on the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, to determine whether there was an altered pancreatic cancer risk associated with H. pylori infection and chronic corpus atrophic gastritis. Conditional logistic regression models were applied to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs), adjusted for matching factors and other potential confounders. Our results showed that pancreatic cancer risk was neither associated with H. pylori seropositivity (OR = 0.96; 95% CI: 0.70, 1.31) nor CagA seropositivity (OR = 1.07; 95% CI: 0.77, 1.48). We also did not find any excess risk among individuals seropositive for H. pylori but seronegative for CagA, compared with the group seronegative for both antibodies (OR = 0.94; 95% CI: 0.63, 1.38). However, we found that chronic corpus atrophic gastritis was non-significantly associated with an increased pancreatic cancer risk (OR = 1.35; 95% CI: 0.77, 2.37), and although based on small numbers, the excess risk was particularly marked among individuals seronegative for both H. pylori and CagA (OR = 5.66; 95% CI: 1.59, 20.19, p value for interaction < 0.01). Our findings provided evidence supporting the null association between H. pylori infection and pancreatic cancer risk in western European populations. However, the suggested association between chronic corpus atrophic gastritis and pancreatic cancer risk warrants independent verification in future studies, and, if confirmed, further studies on the underlying mechanisms. © 2016 UICC
- Published
- 2017
18. Systematic Review with Meta-analysis: Endoscopic and Surgical Resection for Ampullary Lesions
- Author
-
Heise, C., Ali, E., Hasenclever, D., Auriemma, F., Gulla, A., Regner, S., Gaujoux, S., and Hollenbach, M.
- Published
- 2020
- Full Text
- View/download PDF
19. OC.01.2 A SYSTEMATIC REVIEW AND META-ANALYSIS OF ENDOSCOPIC AND SURGICAL RESECTION FOR AMPULLARY LESIONS
- Author
-
Heise, C., Auriemma, F., Abou Ali, E., Hasencelever, D., Gulla, A., Regner, S., Gaujoux, S., and Hollenbach, M.
- Published
- 2020
- Full Text
- View/download PDF
20. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
- Author
-
Löhr, M., Dominguez-Munoz, J.E., Besselink, M., Mayerle, J., Rosendahl, J., Lerch, M.M., Akisik, F., Kartalis, N., Manfredi, R., Iglesias-Garcia, J., Haas, S.L., Keller, J., Boermeester, M.A., Werner, J., Dumonceau, J.M., Fockens, P., Drewes, A., Cheyan, G.O., Lindkvist, B., Drenth, J.P., Ewald, N., Hardt, P., de Madaria, E., Gheorghe, C., Lindgren, F., Schneider, A., Witt, H., Bollen, T., Boraschi, P., Frøkjær, J.B., Rudolf, S., Bruno, M., Dimcevski, G., Giovannini, M., Pukitis, A., Petrone, M., Oppong, K., Ammori, B., Friess, H., Izbiki, J.R., Ganeh, P., Salvia, R., Sauvanet, A., Barbu, S., Lyadov, V., Deprez, P., Gubergrits, N., Okhlobystiy, A.V., Arvanitakis, M., Costamagna, G., Pap, A., Andersson, R., Hauge, T., McKay, C., Regnér, S., Dite, P., Olesen, S.S., Duggan, S., Hopper, A., Phillips, M., Shvets, O., Vujasinovic, M., Czako, L., Piemonti, L., Kocher, H., Rebours, V., Stimac, D., Hegyi, P., Drewes, A.M., Czakó, L., and Löhr, J.M.
- Published
- 2020
- Full Text
- View/download PDF
21. Dietary total antioxidant capacity and gastriccancer risk in the European prospective investigation into cancer and nutritionstudy
- Author
-
Serafini M, Jakszyn P, Luján L, Agudo A, Bas Bueno de Mesquita H, van Duijnhoven FJ, Jenab M, Navarro C, Palli D, Boeing H, Wallström P, Regnér S, Numans ME, Carneiro F, Boutron Ruault MC, Clavel Chapelon F, Morois S, Grioni S, Tumino R, Sacerdote C, Ramon Quirós J, Molina Montes E, Huerta Castaño JM, Barricarte A, Amiano P, Khaw KT, Wareham N, Allen NE, Key TJ, Jeurnink SM, Peeters PH, Bamia C, Valanou E, Trichopoulou A, Kaaks R, Lukanova A, Bergmann MM, Lindkvist B, Stenling R, Johansson I, Dahm CC, Overvad K, Jensen M, Olsen A, Tjonneland A, Bakken K, Dumeaux V, Lund E, McCormack V, Rinaldi S, Michaud D, Mouw T, Riboli E, González C.A., PANICO, SALVATORE, Serafini, M, Jakszyn, P, Luján, L, Agudo, A, Bas Bueno de Mesquita, H, van Duijnhoven, Fj, Jenab, M, Navarro, C, Palli, D, Boeing, H, Wallström, P, Regnér, S, Numans, Me, Carneiro, F, Boutron Ruault, Mc, Clavel Chapelon, F, Morois, S, Grioni, S, Panico, Salvatore, Tumino, R, Sacerdote, C, Ramon Quirós, J, Molina Montes, E, Huerta Castaño, Jm, Barricarte, A, Amiano, P, Khaw, Kt, Wareham, N, Allen, Ne, Key, Tj, Jeurnink, Sm, Peeters, Ph, Bamia, C, Valanou, E, Trichopoulou, A, Kaaks, R, Lukanova, A, Bergmann, Mm, Lindkvist, B, Stenling, R, Johansson, I, Dahm, Cc, Overvad, K, Jensen, M, Olsen, A, Tjonneland, A, Bakken, K, Dumeaux, V, Lund, E, Mccormack, V, Rinaldi, S, Michaud, D, Mouw, T, Riboli, E, and González, C. A.
- Published
- 2012
22. Hepatocellularcarcinoma risk factors and disease burden in a European cohort: a nestedcase-control study
- Author
-
Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Tumino R, Sacerdote C, Bueno De Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E., PANICO, SALVATORE, Trichopoulos, D, Bamia, C, Lagiou, P, Fedirko, V, Trepo, E, Jenab, M, Pischon, T, Nöthlings, U, Overved, K, Tjønneland, A, Outzen, M, Clavel Chapelon, F, Kaaks, R, Lukanova, A, Boeing, H, Aleksandrova, K, Benetou, V, Zylis, D, Palli, D, Pala, V, Panico, Salvatore, Tumino, R, Sacerdote, C, Bueno De Mesquita, Hb, Van Kranen, Hj, Peeters, Ph, Lund, E, Quirós, Jr, González, Ca, Sanchez Perez, Mj, Navarro, C, Dorronsoro, M, Barricarte, A, Lindkvist, B, Regnér, S, Werner, M, Hallmans, G, Khaw, Kt, Wareham, N, Key, T, Romieu, I, Chuang, Sc, Murphy, N, Boffetta, P, Trichopoulou, A, and Riboli, E.
- Published
- 2011
23. Prediction of mild disease in acute pancreatitis using routine and non-routine biomarkers
- Author
-
Sternby, H., primary, Hartman, H., additional, Johansen, D., additional, Thorlacius, H., additional, and Regnér, S., additional
- Published
- 2016
- Full Text
- View/download PDF
24. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective investigation into cancer and nutrition
- Author
-
Jeurnink, SM, Büchner, FL, Bueno-de-Mesquita, HB, Siersema, PD, Boshuizen, HC, Numans, ME, Dahm, CC, Overvad, K, Tjønneland, A, Roswall, N, Clavel-Chapelon, F, Boutron-Ruault, MC, Morois, S, Kaaks, R, Teucher, B, Boeing, H, Buijsse, B, Trichopoulou, A, Benetou, V, Zylis, D, Palli, D, Sieri, S, Vineis, P, Tumino, R, Panico, S, Ocké, MC, Peeters, PHM, Skeie, G, Brustad, M, Lund, E, Sánchez-Cantalejo, E, Navarro, C, Amiano, P, Ardanaz, E, Quirós, J Ramón, Hallmans, Göran, Johansson, I, Lindkvist, B, Regnér, S, Khaw, KT, Wareham, N, Key, TJ, Slimani, N, Norat, T, Vergnaud, AC, Romaguera, D, Gonzalez, CA, Jeurnink, SM, Büchner, FL, Bueno-de-Mesquita, HB, Siersema, PD, Boshuizen, HC, Numans, ME, Dahm, CC, Overvad, K, Tjønneland, A, Roswall, N, Clavel-Chapelon, F, Boutron-Ruault, MC, Morois, S, Kaaks, R, Teucher, B, Boeing, H, Buijsse, B, Trichopoulou, A, Benetou, V, Zylis, D, Palli, D, Sieri, S, Vineis, P, Tumino, R, Panico, S, Ocké, MC, Peeters, PHM, Skeie, G, Brustad, M, Lund, E, Sánchez-Cantalejo, E, Navarro, C, Amiano, P, Ardanaz, E, Quirós, J Ramón, Hallmans, Göran, Johansson, I, Lindkvist, B, Regnér, S, Khaw, KT, Wareham, N, Key, TJ, Slimani, N, Norat, T, Vergnaud, AC, Romaguera, D, and Gonzalez, CA
- Abstract
BACKGROUND: Diets high in vegetables and fruits have been suggested to be inversely associated with risk of gastric cancer. However, the evidence of the effect of variety of consumption is limited. We therefore investigated whether consumption of a variety of vegetables and fruit is associated with gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. METHODS: Data on food consumption and follow-up on cancer incidence was available for 452,269 participants from 10 European countries. After a mean follow-up of 8.4 years, 475 cases of gastric and esophageal adenocarcinomas (180 non-cardia, 185 cardia, gastric esophageal junction and esophagus, 110 not specified) and 98 esophageal squamous cell carcinomas were observed. Diet Diversity Scores (DDSs) were used to quantify the variety in vegetable and fruit consumption. We used multivariable Cox proportional hazard models to calculate risk ratios. RESULTS: Independent from quantity of consumption, variety in the consumption of vegetables and fruit combined and of fruit consumption alone were statistically significantly inversely associated with the risk of esophageal squamous cell carcinoma (continuous HR per 2 products increment 0.88; 95%CI 0.79-0.97 and 0.76; 95%CI 0.62-0.94, respectively) with the latter particularly seen in ever smokers. Variety in vegetable and/or fruit consumption was not associated with risk of gastric and esophageal adenocarcinomas. CONCLUSION: Independent from quantity of consumption, more variety in vegetable and fruit consumption combined and in fruit consumption alone may decrease the risk of esophageal squamous cell carcinoma. However, residual confounding by lifestyle factors can not be excluded. © 2012 Wiley-Liss, Inc.
- Published
- 2012
- Full Text
- View/download PDF
25. Preset cut-off levels for predictive biomarkers in severe acute pancreatitis – Have we reached that far?
- Author
-
Sternby, H., Hartman, H., Johansen, D., Thorlacius, H., and Regner, S.
- Published
- 2016
- Full Text
- View/download PDF
26. Extrapancreatic necrosis is not uniformly identified by european radiologists - a prospective multicenter evaluation of the revised Atlanta classification
- Author
-
Sternby, H., Verdonk, R.C., Aguilar, G., Dimova, A., Ignatavicius, P., Ilzarbe, L., Koiva, P., Lantto, E., Loigom, T., Pentillä, A., Regner, S., Rosendahl, J., Strahinova, V., Zackrisson, S., Zviniene, K., and Bollen, T.L.
- Published
- 2016
- Full Text
- View/download PDF
27. IL-6 Trans-signaling vermittelt über die Aktivierung von Stat3 das letale Lungenversagen der schweren akuten Pankreatitis
- Author
-
Hong, Z, primary, Neuhöfer, P, additional, Liang, S, additional, Rabe, B, additional, Lesina, M, additional, Kurkowski, MU, additional, Treiber, M, additional, Wartmann, T, additional, Regnér, S, additional, Thorlacius, H, additional, Saur, D, additional, Yoshimura, A, additional, Halangk, W, additional, Mizgerd, JP, additional, Rose-John, S, additional, Schmid, RM, additional, and Algül, H, additional
- Published
- 2012
- Full Text
- View/download PDF
28. P-selectin mediates neutrophil rolling and recruitment in acute pancreatitis
- Author
-
Hartman, H, primary, Abdulla, A, additional, Awla, D, additional, Lindkvist, B, additional, Jeppsson, B, additional, Thorlacius, H, additional, and Regnér, S, additional
- Published
- 2011
- Full Text
- View/download PDF
29. Role of platelets in experimental acute pancreatitis
- Author
-
Abdulla, A, primary, Awla, D, additional, Hartman, H, additional, Rahman, M, additional, Jeppsson, B, additional, Regnér, S, additional, and Thorlacius, H, additional
- Published
- 2010
- Full Text
- View/download PDF
30. ACTIVE CARBOXYPEPTIDASE B IS PRESENT IN FREE FORM IN SERUM IN ACUTE PANCREATITIS IN MAN.
- Author
-
Regnér, S., primary and Borgström, A., additional
- Published
- 2004
- Full Text
- View/download PDF
31. Ergosterol content in relation to grain kernel weight
- Author
-
Regnér, S., Schnürer, Johan, Jonsson, A., Regnér, S., Schnürer, Johan, and Jonsson, A.
- Abstract
The relation between fungal biomass content and grain kernel weight was investigated in five lots of grain: three wheat, one rye, and one triticale. Fungal biomass was quantified as ergosterol content. Samples were fractionated on the basis of grain kernel weight using an automatic sorter. In all lots, ergosterol concentrations increased as kernel weight decreased. In four of the five lots, the absolute amount of ergosterol per kernel also increased with decreasing kernel weight. Within-cultivar variation in ergosterol levels could not be explained solely by differences in surface-to-volume ratio. Ergosterol concentrations in the impurities (material not classified as whole, sound kernels) were generally several times higher than those in the original lots. Although concentrations of ergosterol were relatively high in small kernels and impurities, removal of these fractions did not significantly influence the average ergosterol levels of the lots, due to the low relative weight of these fractions. Separation during handling of the grain might, however, lead to extreme ergosterol concentrations in certain locations of the storage bins. These locations can serve as potential starting points for mold growth.
- Published
- 1994
32. Chemical Composition of Barley Cultivars Fractionated by Weighing, Pneumatic Classification, Sieving, and Sorting on a Specific Gravity Table
- Author
-
Elfverson, C., primary, Andersson, A. A. M., additional, Åman, P., additional, and Regnér, S., additional
- Published
- 1999
- Full Text
- View/download PDF
33. Germination characteristics of seeds differing in mass
- Author
-
Milberg, P., primary, Andersson, L., additional, Elfverson, C., additional, and Regnér, S., additional
- Published
- 1996
- Full Text
- View/download PDF
34. Response
- Author
-
Rudolf Kaaks, Aurelio Barricarte, Annekatrin Lukanova, H. Bas Bueno-de-Mesquita, Eiliv Lund, Carlos González, Elisabeth Trepo, Elio Riboli, Isabelle Romieu, Heiner Boeing, J. Ramón Quirós, Malene Outzen, Henk J. van Kranen, Petra H.M. Peeters, Pagona Lagiou, Françoise Clavel-Chapelon, Vassiliki Benetou, Carmen Navarro, Krasimira Aleksandrova, Christina Bamia, Paolo Boffetta, Sara Regnér, Nicholas J. Wareham, Maria-Jose Sanchez Perez, Veronika Fedirko, Shu Chun Chuang, Miren Dorronsoro, Mazda Jenab, Kim Overvad, Anne Tjønneland, Göran Hallmans, Antonia Trichopoulou, Valeria Pala, Neil Murphy, Dimitrios Trichopoulos, Ute Nthlings, Carlotta Sacerdote, Salvatore Panico, Kay-Tee Khaw, Bjoern Lindkvist, Rosario Tumino, Timothy J. Key, Mårten Werner, Dimosthenis Zylis, Tobias Pischon, Domenico Palli, Trichopoulos, D., Bamia, C., Lagiou, P., Fedirko, V., Trepo, E., Jenab, M., Pischon, T., Nöthlings, U., Overvad, K., Tjonneland, A., Outzen, M., Clavel-Chapelon, F., Kaaks, R., Lukanova, A., Boeing, H., Aleksandrova, K., Benetou, V., Zylis, D., Palli, D., Pala, V., Panico, S., Tumino, R., Sacerdote, C., Bueno-De-Mesquita, H.B., Van Kranen, H.J., Peeters, P.H.M., Lund, E., Quirós, J.R., González, C.A., Sanchez Perez, M.-J., Navarro, C., Dorronsoro, M., Barricarte, A., Lindkvist, B., Regnér, S., Werner, M., Hallmans, G., Khaw, K.-T., Wareham, N., Key, T., Romieu, I., Chuang, S.-C., Murphy, N., Boffetta, P., Trichopoulou, A., and Riboli, E.
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Response ,medicine.disease ,digestive system diseases ,Internal medicine ,Hepatocellular carcinoma ,Cohort ,Nested case-control study ,medicine ,business ,Disease burden - Abstract
Re : Hepatocellular Carcinoma Risk factors and Disease Burden in a European Cohort: A Nested Case-Control Study Response
- Published
- 2012
35. Hepatocellular carcinoma risk factors and disease burden in a European cohort:a nested case-control study
- Author
-
Christina Bamia, Tobias Pischon, Elisabeth Trepo, Petra H.M. Peeters, Domenico Palli, Heiner Boeing, J. Ramón Quirós, Miren Dorronsoro, Kim Overved, Françoise Clavel-Chapelon, Carlos González, Vassiliki Benetou, Timothy J. Key, Rudolf Kaaks, Mårten Werner, Carlotta Sacerdote, Dimosthenis Zylis, Carmen Navarro, Pagona Lagiou, Shu Chun Chuang, Mazda Jenab, Göran Hallmans, Henk J. van Kranen, Krasimira Aleksandrova, Björn Lindkvist, Isabelle Romieu, Ute Nöthlings, Aurelio Barricarte, Paolo Boffetta, María José Sánchez Pérez, Rosario Tumino, Valeria Pala, Annekatrin Lukanova, H. Bas Bueno-de-Mesquita, Nicholas J. Wareham, Antonia Trichopoulou, Eiliv Lund, Neil Murphy, Kay-Tee Khaw, Sara Regnér, Elio Riboli, Malene Outzen, Anne Tjønneland, Dimitrios Trichopoulos, Veronika Fedirko, Salvatore Panico, Trichopoulos, D., Bamia, C., Lagiou, P., Fedirko, V., Trepo, E., Jenab, M., Pischon, T., Nöthlings, U., Overved, K., Tjønneland, A., Outzen, M., Clavel-Chapelon, F., Kaaks, R., Lukanova, A., Boeing, H., Aleksandrova, K., Benetou, V., Zylis, D., Palli, D., Pala, V., Panico, S., Tumino, R., Sacerdote, C., Bueno-De-Mesquita, H.B., Van Kranen, H.J., Peeters, P.H.M., Lund, E., Quirós, J.R., González, C.A., Sanchez Perez, M.-J., Navarro, C., Dorronsoro, M., Barricarte, A., Lindkvist, B., Regnér, S., Werner, M., Hallmans, G., Khaw, K.-T., Wareham, N., Key, T., Romieu, I., Chuang, S.-C., Murphy, N., Boffetta, P., Trichopoulou, A., and Riboli, E.
- Subjects
Male ,Cancer Research ,european cohort ,carcinoma ,burden ,Cohort Studies ,0302 clinical medicine ,Cost of Illness ,Risk Factors ,Odds Ratio ,Prevalence ,Prospective Studies ,Prospective cohort study ,Incidence ,Liver Neoplasms ,Smoking ,Middle Aged ,3. Good health ,Europe ,Oncology ,risk factor ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Cohort ,030211 gastroenterology & hepatology ,Female ,Risk assessment ,case-control ,Cohort study ,Adult ,Carcinoma, Hepatocellular ,Alcohol Drinking ,Risk Assessment ,03 medical and health sciences ,nested ,Hepatitis B, Chronic ,Environmental health ,medicine ,Humans ,Obesity ,Life Style ,Disease burden ,Aged ,business.industry ,Retrospective cohort study ,Hepatocellular ,Feeding Behavior ,Hepatitis C, Chronic ,medicine.disease ,Case-Control Studies ,Immunology ,Nested case-control study ,Food Habits ,business ,Follow-Up Studies - Abstract
Background To date, no attempt has been made to systematically determine the apportionment of the hepatocellular carcinoma burden in Europe or North America among established risk factors. Methods Using data collected from 1992 to 2006, which included 4409809 person-years in the European Prospective Investigation into Cancer and nutrition (EPIC), we identified 125 case patients with hepatocellular carcinoma, of whom 115 were matched to 229 control subjects. We calculated odds ratios (ORs) for the association of documented risk factors for hepatocellular carcinoma with incidence of this disease and estimated their importance in this European cohort. Results Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (OR = 9.10, 95% confidence interval [CI] = 2.10 to 39.50 and OR = 13.36, 95% CI = 4.11 to 43.45, respectively), obesity (OR = 2.13, 95% CI = 1.06 to 4.29), former or current smoking (OR = 1.98, 95% CI = 0.90 to 4.39 and OR = 4.55, 95% CI = 1.90 to 10.91, respectively), and heavy alcohol intake (OR = 1.77, 95% CI = 0.73 to 4.27) were associated with hepatocellular carcinoma. Smoking contributed to almost half of all hepatocellular carcinomas (47.6%), whereas 13.2% and 20.9% were attributable to chronic HBV and HCV infection, respectively. Obesity and heavy alcohol intake contributed 16.1% and 10.2%, respectively. Almost two-thirds (65.7%, 95% CI = 50.6% to 79.3%) of hepatocellular carcinomas can be accounted for by exposure to at least one of these documented risk factors. Conclusions Smoking contributed to more hepatocellular carcinomas in this Europe-wide cohort than chronic HBV and HCV infections. Heavy alcohol consumption and obesity also contributed to sizeable fractions of this disease burden. These contributions may be underestimates because EPIC volunteers are likely to be more health conscious than the general population. © 2011 The Author.
- Published
- 2011
- Full Text
- View/download PDF
36. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in theEuropean Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Anja Olsen, Signe Borgquist, Rosario Tumino, Carlotta Sacerdote, Pagona Lagiou, Elio Riboli, Kim Overvad, Sara Regnér, Christina Bamia, Laudina Rodríguez, Kay-Tee Khaw, Bas Bueno-de-Mesquita, Paolo Vineis, Carmen Navarro, Nikolaus Becker, Manuela M. Bergmann, Anne Tjønneland, María José Sánchez, Nicholas J. Wareham, Rudolf Kaaks, Salvatore Panico, Pascale Berthillon, Roel Vermeulen, Ruth C. Travis, Mauro Lise, Beatrice Melin, Domenico Palli, Shu Chun Chuang, Göran Hallmans, Sabina Rinaldi, Alexandra Nieters, Leila Luján Barroso, Antonia Trichopoulou, Silvia Franceschi, Christian Trepo, Pierre Hainaut, Miren Dorronsoro, Heiner Boeing, Sabina Sieri, Aurelio Barricarte, Petra H.M. Peeters, Franceschi, S, Lise, M, Trépo, C, Berthillon, P, Chuang, Sc, Nieters, A, Travis, Rc, Vermeulen, R, Overvad, K, Tjønneland, A, Olsen, A, Bergmann, Mm, Boeing, H, Kaaks, R, Becker, N, Trichopoulou, A, Lagiou, P, Bamia, C, Palli, D, Sieri, S, Panico, Salvatore, Tumino, R, Sacerdote, C, Bueno de Mesquita, B, Peeters, Ph, Rodríguez, L, Barroso, Ll, Dorronsoro, M, Sánchez, Mj, Navarro, C, Barricarte, A, Regnér, S, Borgquist, S, Melin, B, Hallmans, G, Khaw, Kt, Wareham, N, Rinaldi, S, Hainaut, P, Riboli, E, Vineis, P., Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), E16, IFR Laennec (IL), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre de Recherche en Cancérologie de Lyon (CRCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (CRCL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Molecular Epidemiology, Center of Chronic Immunodeficiency, University Medical Center and University of Freiburg, Institute for Medical Biostatistics and Medical Informatics, University Medical Center and University of Freiburg, Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Section of Epidemiology, Aarhus University [Aarhus], Danish Cancer Society Research Center, Cancer Epidemiology Institute, Danish Cancer Society, Epidemiology, Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Hellenic Health Foundation, WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene-Epidemiology and Medical Statistics-Athens Medical School, WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Clinical and Experimental Medicine, Università degli studi di Napoli Federico II, Cancer Registry, Azienda Ospedaliera 'Civile M.P.Arezzo', CPO Piemonte, National Institute for Public Health and the Environment [Bilthoven] (RIVM), Department of Gastroenterology and Hepatology, University Medical Centre, Julius Centre for Health Sciences and Primary Care, VU University Medical Center [Amsterdam], Julius Center for Health Sciences and Primary Care, Public Health and Participation Directorate, Health and Health Care Services Council, Epidemiology and Health Information, Public Health Department of Gipuzkoa, Consorcio de Investigación Biomédica en Red especializado en Epidemiología y Salud Pública (CIBERESP), Los Centros de Investigación Biomédica en Red (CIBER), Granada Cancer Registry, Andalusian School of Public Health [Granada], CIBERESP, CIBER Epidemiologia y Salud Pública, Epidemiology Department, Murcia Health Council, Navarre Public Health Institute, Department of Oncology, Lund University [Lund]-Lund University Hospital, Department of Radiation Sciences and Oncology, Umeå University, Department of Public Health and Clinical Medicine, Department of Public Health and Primary Care, University of Cambridge [UK] (CAM), Medical Research Council, Addenbrooke's Hospital-Epidemiology Unit, International Agency for Cancer Research (IACR), Sect Mech Carcinogenesis, School of Public Health, Imperial College London, Centre for Environment and Health, Imperial College London-School of public health, The University of Hong Kong (HKU)-The University of Hong Kong (HKU), Human Genetics Foundation (HuGeF), Università degli studi di Torino (UNITO), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Freiburg University Medical Center, Civile - M.P.Arezzo Hospital, and Lund University Hospital-Lund University [Lund]
- Subjects
Male ,HBsAg ,Epidemiology ,medicine.disease_cause ,Gastroenterology ,0302 clinical medicine ,MESH: Lymphoma, Non-Hodgkin ,MESH: Risk Factors ,Risk Factors ,immune system diseases ,hemic and lymphatic diseases ,Prospective Studies ,MESH: Middle Aged ,Lymphoma, Non-Hodgkin ,virus diseases ,Hepatitis C ,Hepatitis B ,Middle Aged ,MESH: Case-Control Studies ,3. Good health ,European Prospective Investigation into Cancer and Nutrition ,Europe ,Oncology ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Female ,medicine.medical_specialty ,Hepatitis C virus ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Risk factor ,Hepatitis B virus ,MESH: Hepatitis C ,MESH: Humans ,MESH: Hepatitis B ,business.industry ,Odds ratio ,medicine.disease ,digestive system diseases ,MESH: Male ,MESH: Prospective Studies ,Case-Control Studies ,Immunology ,MESH: Europe ,business ,MESH: Female - Abstract
Background: Case–control studies suggested a moderate, but consistent, association of hepatitis C virus (HCV) infection with lymphoid tissue malignancies, especially non–Hodgkin lymphoma (NHL). More limited data suggested that hepatitis B virus (HBV) infection might also be associated with NHL. However, prospective studies on the topic are few. Methods: A nested case–control study was conducted in eight countries participating in the EPIC prospective study. Seven hundred thirty-nine incident cases of NHL, 238 multiple myeloma (MM), and 46 Hodgkin lymphoma (HL) were matched with 2,028 controls. Seropositivity to anti-HCV, anti-HBc, and HBsAg was evaluated and conditional logistic regression was used to estimate odds ratios (OR) and corresponding 95% confidence intervals (CI) for NHL, MM, or HL, and their combination. Results: Anti-HCV seropositivity among controls in different countries ranged from 0% to 5.3%; HBsAg from 0% to 2.7%; and anti-HBc from 1.9% to 45.9%. Similar nonsignificant associations were found with seropositivity to HBsAg for NHL (OR = 1.78; 95% CI: 0.78–4.04), MM (OR = 4.00; 95% CI: 1.00–16.0), and HL (OR = 2.00; 95% CI: 0.13–32.0). The association between HBsAg and the combination of NHL, MM, and HL (OR = 2.21; 95% CI: 1.12–4.33) was similar for cancer diagnosed less than 3 and 3 or more years after blood collection. No significant association was found between anti-HCV and NHL, MM, or HL risk, but the corresponding CIs were very broad. Conclusions: Chronic HBV infection may increase the risk of lymphoid malignancies among healthy European volunteers. Impact: Treatment directed at control of HBV infection should be evaluated in HBsAg-seropositive patients with lymphoid tissue malignancies. Cancer Epidemiol Biomarkers Prev; 20(1); 208–14. ©2011 AACR.
- Published
- 2011
- Full Text
- View/download PDF
37. Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study
- Author
-
Miren Dorronsoro, Françoise Clavel-Chapelon, Sophie Morois, Sheila Bingham, Majken K. Jensen, Elio Riboli, Domenico Palli, Antonia Trichopoulou, Sara Regnér, Paula Jakszyn, Dora Romaguera, Carmen Navarro, Heiner Boeing, Rosario Tumino, Roger Stenling, Paolo Boffeta, Marie-Christine Boutron-Ruault, Genevieve Buckland, Salvatore Panico, Marga C. Ocké, Aurelio Barricarte, Mattijs E. Numans, Elisabeth Couto, Jonas Manjer, Dimitrios Trichopoulos, Pagona Lagiou, Kim Overvad, J. Ramón Quirós, Mazda Jenab, Naomi E. Allen, Anne Tjønneland, Gabriella Nesi, Timothy J. Key, Leila Luján, Petra H.M. Peeters, Carlotta Sacerdote, Ingegerd Johansson, Anja Olsen, Carlos A. González, H. Bas Bueno-de-Mesquita, Traci Mouw, Antonio Agudo, Fátima Carneiro, Eiliv Lund, María José Sánchez, Vittorio Krogh, Rudolf Kaaks, Buckland, G, Agudo, A, Luján, L, Jakszyn, P, Bueno de Mesquita, Hb, Palli, D, Boeing, H, Carneiro, F, Krogh, V, Sacerdote, C, Tumino, R, Panico, Salvatore, Nesi, G, Manjer, J, Regnér, S, Johansson, I, Stenling, R, Sanchez, Mj, Dorronsoro, M, Barricarte, A, Navarro, C, Quirós, Jr, Allen, Ne, Key, Tj, Bingham, S, Kaaks, R, Overvad, K, Jensen, M, Olsen, A, Tjønneland, A, Peeters, Ph, Numans, Me, Ocké, Mc, Clavel Chapelon, F, Morois, S, Boutron Ruault, Mc, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Lund, E, Couto, E, Boffeta, P, Jenab, M, Riboli, E, Romaguera, D, Mouw, T, and González, Ca
- Subjects
Questionnaires ,Adult ,Male ,medicine.medical_specialty ,Mediterranean diet ,Population ,Medicine (miscellaneous) ,prevention & control ,Adenocarcinoma ,Diet, Mediterranean ,Europe/epidemiology ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Stomach Neoplasms ,Internal medicine ,Surveys and Questionnaires ,medicine ,Humans ,030212 general & internal medicine ,Prospective Studies ,Stomach cancer ,education ,Prospective cohort study ,Aged ,Proportional Hazards Models ,education.field_of_study ,Nutrition and Dietetics ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,3. Good health ,European Prospective Investigation into Cancer and Nutrition ,Surgery ,Europe ,030220 oncology & carcinogenesis ,Female ,business ,Cohort study - Abstract
BACKGROUND: The Mediterranean dietary pattern is believed to protect against cancer, although evidence from cohort studies that have examined particular cancer sites is limited. OBJECTIVE: We aimed to explore the association between adherence to a relative Mediterranean diet (rMED) and incident gastric adenocarcinoma (GC) within the European Prospective Investigation into Cancer and Nutrition study. DESIGN: The study included 485,044 subjects (144,577 men) aged 35-70 y from 10 European countries. At recruitment, dietary and lifestyle information was collected. An 18-unit rMED score, incorporating 9 key components of the Mediterranean diet, was used to estimate rMED adherence. The association between rMED and GC with respect to anatomic location (cardia and noncardia) and histologic types (diffuse and intestinal) was investigated. A calibration study in a subsample was used to control for dietary measurement error. RESULTS: After a mean follow-up of 8.9 y, 449 validated incident GC cases were identified and used in the analysis. After stratification by center and age and adjustment for recognized cancer risk factors, high compared with low rMED adherence was associated with a significant reduction in GC risk (hazard ratio: 0.67; 95% CI: 0.47, 0.94). A 1-unit increase in the rMED score was associated with a decreased risk of GC of 5% (95% CI: 0.91, 0.99). There was no evidence of heterogeneity between different anatomic locations or histologic types. The calibrated results showed similar trends (overall hazard ratio for GC: 0.93; 95% CI: 0.89, 0.99). CONCLUSION: Greater adherence to an rMED is associated with a significant reduction in the risk of incident GC. Some authors are partners of ECNIS, a network of excellence of the EC (6FP contract 513943).
- Published
- 2009
- Full Text
- View/download PDF
38. Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis.
- Author
-
Hollenbach M, Heise C, Abou-Ali E, Gulla A, Auriemma F, Soares K, Leung G, Schattner MA, Jarnagin WR, Wang T, Caillol F, Giovannini M, Dahel Y, Hackert T, Paik WH, Zerbi A, Nappo G, Napoleon B, Arnelo U, Haraldsson E, Halimi A, Waldthaler A, Will U, Saadeh R, Masaryk V, van der Wiel SE, Bruno MJ, Perez-Cuadrado-Robles E, Deprez P, Sauvanet A, Bolm L, Keck T, Souche R, Fabre JM, Musquer N, Kähler G, Seyfried S, Petrone MC, Mariani A, Zaccari P, Belfiori G, Crippa S, Falconi M, Partelli S, Yilmaz B, Demir IE, Ceyhan GO, Satoi S, Regimbeau JM, Gagniére J, Repici A, Anderloni A, Vollmer C, Casciani F, Del Chiaro M, Oba A, Schulick RD, Berger A, Maggino L, Salvia R, Schemmer P, Wichmann D, Inoue Y, Dinis-Ribeiro M, Laranjo A, Libanio D, Kleemann T, Sandru V, Ilie M, Ahola R, Laukkarinen J, Schumacher B, Albers D, Cúrdia Gonçalves T, Barbier L, Salamé E, Weismüller TJ, Heling D, Alves A, Karam E, Regenet N, Dugic A, Muehldorfer S, Truant S, Caca K, Meier B, Miutescu BP, Tantau M, Birnbaum D, Miksch RC, Wedi E, Salzmann K, Bruzzi M, Lupinacci RM, David P, De Ponthaud C, Schmidt A, Regnér S, and Gaujoux S
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Pancreaticoduodenectomy methods, Propensity Score, Treatment Outcome, Sphincterotomy, Endoscopic methods, Ampulla of Vater surgery, Ampulla of Vater pathology, Common Bile Duct Neoplasms surgery, Common Bile Duct Neoplasms pathology, Common Bile Duct Neoplasms mortality, Adenoma surgery, Adenoma pathology
- Abstract
Objective: Ampullary neoplastic lesions can be resected by endoscopic papillectomy (EP) or transduodenal surgical ampullectomy (TSA) while pancreaticoduodenectomy is reserved for more advanced lesions. We present the largest retrospective comparative study analysing EP and TSA., Design: Of all patients in the database, lesions with prior interventions, benign histology advanced malignancy (T2 and more), patients with hereditary syndromes and those undergoing pancreatoduodenectomy were excluded. All remaining cases as well as a subgroup of them, after propensity-score matching (nearest-neighbour-method) based on age, gender, anthropometrics, comorbidities, size and histological subtype, were analysed. The median follow-up was 21 months (IQR 10-47) after the primary intervention. Primary outcomes were rates of complete resection (R0) and complications. Groups were compared by Fisher's exact or χ
2 test, Mann-Whitney-U-test and log-rank test for survival., Results: Of 1673 patients in the database, 1422 underwent EP and 251 TSA. Of them, 23.2% were excluded for missing or inconclusive data and 19.8% of patients for prior interventions or hereditary syndromes. Final histology showed in 24.2% of EP and 14.8% of TSA patients a histology other than adenoma or adenocarcinoma while advanced cancers were recorded in 10.9% of EP and 36.6% of TSA patients. Finally, 569 EP and 63 TSA were included in the overall analysis, with a higher rate of more advanced cases and higher R0 resection rates in the TSA groups (90.5% vs 73.1%; p<0.01), with additional ablation in the EP group in 14.4%. Severe adverse event rates were 3.2% (TSA) vs 1.9% (EP). Recurrence after histological R0 resection was 16% (EP) vs 3.2% (TSA; p=0.01), and additional therapy for R1 resection was applied in 67% of the 159 cases. Propensity-score-based matching identified 62 pairs of EP/TSA patients with comparable baseline patient and lesion characteristics. The initial R0-rate was 72.6% (EP) compared with 90.3% (TSA, p=0.02) with recurrences found in 8% (EP) vs 3.2% (TSA; p=0.07); reinterventions were more frequent in the EP group. Overall survival was comparable., Conclusions: The rate of patients with poor indications due to non-neoplastic disease or advanced cancer is still high for both EP and TSA; multiple retreatments were necessary for EP. Although EP can be considered an appropriate primary therapy for certain ampullary adenomas, case selection for both therapies (especially with regard to the best step-up approach) should be studied further., Competing Interests: Competing interests: MH: Honoraria from FUJIFILM for lectures and expert panel. Honoraria from Falk Foundation for lectures. MBruno: Boston Scientific: consultant (money to institution), support for industry and investigator-initiated studies. Cook Medical: consultant (money to institution), support for industry and investigator-initiated studies. Pentax Medical: consultant (money to institution), support for investigator-initiated studies. Mylan: lecturer, support for investigator-initiated studies. ChiRoStim: support for investigator-initiated studies.MDC received a research grant Boston from Haemonetics,INC and he is co-PI of a Boston Scientific sponsored study, (© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.)- Published
- 2025
- Full Text
- View/download PDF
39. Assessing Patient Radiation Exposure in Endoscopic Retrograde Cholangiopancreatography: A Multicenter Retrospective Analysis of Procedural Complexity and Clinical Factors.
- Author
-
Kaasalainen T, Saukko E, Lindström O, Udd M, Regnér S, Saarela A, Toth E, Wurm Johansson G, Manninen AL, Grönroos J, and Kylänpää L
- Abstract
Background and Aims: Endoscopic retrograde cholangiopancreatography (ERCP) procedures can result in significant patient radiation exposure. This retrospective multicenter study aimed to assess the influence of procedural complexity and other clinical factors on radiation exposure in ERCP., Methods: Data on kerma-area product (KAP), air-kerma at the reference point (K
a,r ), fluoroscopy time, and the number of exposures, and relevant patient, procedure, and operator factors were collected from 2641 ERCP procedures performed at four university hospitals. The influence of procedural complexity, assessed using the American Society for Gastrointestinal Endoscopy (ASGE) and HOUSE complexity grading scales, on radiation exposure quantities was analyzed within each center. The procedures were categorized into two groups based on ERCP indications: primary sclerosing cholangitis (PSC) and other ERCPs., Results: Both the ASGE and HOUSE complexity grading scales had a significant impact on radiation exposure quantities. Remarkably, there was up to a 50-fold difference in dose quantities observed across the participating centers. For non-PSC ERCP procedures, the median KAP ranged from 0.9 to 64.4 Gy·cm2 among the centers. The individual endoscopist also had a substantial influence on radiation dose., Conclusions: Procedural complexity grading in ERCP significantly affects radiation exposure. Higher procedural complexity is typically associated with increased patient radiation dose. The ASGE complexity grading scale demonstrated greater sensitivity to changes in radiation exposure compared to the HOUSE grading scale. Additionally, significant variations in dose indices, fluoroscopy times, and number of exposures were observed across the participating centers.- Published
- 2024
- Full Text
- View/download PDF
40. Laparoscopic transcystic common bile duct exploration versus transgastric endoscopic retrograde cholangiography during cholecystectomy after Roux-en-Y gastric bypass.
- Author
-
Zaigham H, Enochsson L, Ottosson J, and Regnér S
- Subjects
- Humans, Cholecystectomy, Cholangiography, Common Bile Duct, Gastric Bypass, Laparoscopy, Gallstones surgery
- Abstract
Background: Treatment of common bile duct (CBD) stones after Roux-en-Y gastric bypass (RYGB) poses a particular challenge given the altered anatomy and inability to perform a standard endoscopic retrograde cholangiogram (ERC). The optimal treatment strategy for intraoperatively encountered CBD stones in post-RYGB patients has not been established., Objectives: To compare outcomes following laparoscopic transcystic common bile duct exploration (LTCBDE) and laparoscopy-assisted transgastric ERC for CBDs during cholecystectomy in RYGB-operated patients., Setting: Swedish nationwide multi-registry study., Methods: The Swedish Registry for Gallstone Surgery and ERCs, GallRiks (n = 215,670), and the Scandinavian Obesity Surgery Registry (SOReg) (n = 60,479) were cross-matched for cholecystectomies with intraoperatively encountered CBD stones in patients with previous RYGB surgery between 2011 and 2020., Results: Registry cross-matching found 550 patients. Both LTCBDE (n = 132) and transgastric ERC (n = 145) were comparable in terms of low rates of intraoperative adverse events (1% versus 2%) and postoperative adverse events within 30 days (16% versus 18%). LTCBDE required significantly shorter operating time (P = .005) by on average 31 minutes, 95% confidence interval (CI) [10.3-52.6], and was more often used for smaller stones <4 mm in size (30% versus 17%, P = .010). However, transgastric ERC was more often used in acute surgery (78% versus 63%, P = .006) and for larger stones >8 mm in size (25% versus 8%, P < .001)., Conclusions: LTCBDE and transgastric ERC have similarly low complication rates for clearance of intraoperatively encountered CBD stones in RYGB-operated patients, but LTCBDE is faster while transgastric ERC is more often used in conjunction with larger bile duct stones., (Copyright © 2023 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
41. Long-Term Follow-up and Risk of Recurrence of Internal Herniation after Roux-en-Y Gastric Bypass.
- Author
-
Zaigham H, Ekelund M, and Regnér S
- Subjects
- Humans, Follow-Up Studies, Retrospective Studies, Postoperative Complications etiology, Abdominal Pain etiology, Abdominal Pain surgery, Recurrence, Gastric Bypass adverse effects, Gastric Bypass methods, Obesity, Morbid surgery, Hernia, Abdominal etiology, Laparoscopy methods
- Abstract
Purpose: Internal herniation (IH) is the most common complication after Roux-en-Y gastric bypass surgery (RYGB). Although primary closure has reduced the incidence, recurrences are a continued problem. This study aimed to investigate long-term follow-up and recurrence risk of IH surgery., Methods: A retrospective cohort study of laparoscopic RYGB operated patients operated for a first IH between April 2012 and April 2015 at Skåne University Hospital in Malmö, Sweden. Status of primary closure of mesenteric gaps, time since RYGB, and findings at IH surgery were retrieved from medical records. Follow-up until December 31st, 2019, included recurrences of IH, number of computed tomography (CT) scans, emergency visits, readmissions, and other acute surgeries., Results: IH (n = 44) occurred almost equally in Petersen's space (n = 24) and beneath the jejunojejunostomy (n = 20). Long-term follow-up (median 75 months) of 43 patients registered an IH recurrence rate of 14% (n = 6). All recurrences occurred in the other mesenteric gap. One patient suffered a third IH, and one patient had four IH events. During follow-up, 56% (n = 24) had ER visits for abdominal pain, 47% (n = 20) had ≥ 1 abdominal CT scan, and 40% (n = 17) were readmitted. A third of readmitted (6/17) patients suffered a recurrence of internal herniation. Two other patients were readmitted ≥ 10 times for chronic abdominal pain., Conclusion: Surgery for IH had a low risk of recurrence at the treated mesenteric gap, but a 14% recurrence risk at the other mesenteric gap, emphasizing the importance of carefully investigating weaknesses or gaps at the other mesenteric defect during surgery for IH., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Postoperative three-dimensional endoanal ultrasound findings and relation to anal fistula plug failure.
- Author
-
Aho Fält U, Zawadzki A, Starck M, Bohe M, Regnér S, and Johnson LB
- Subjects
- Humans, Retrospective Studies, alpha-Fetoproteins, Anal Canal diagnostic imaging, Anal Canal surgery, Endosonography methods, Imaging, Three-Dimensional methods, Rectal Fistula diagnostic imaging, Rectal Fistula surgery, Fecal Incontinence
- Abstract
Objectives: To explore the utilization of three-dimensional (3D) endoanal ultrasound (EAUS) for the follow-up of the anal fistula plug (AFP), describe morphological findings in postoperative 3D EAUS, and evaluate if postoperative 3D EAUS combined with clinical symptoms can predict AFP failure., Materials and Methods: A retrospective analysis of 3D EAUS examinations performed during a single-centre study of prospectively included consecutive patients treated with the AFP between May 2006 and October 2009. Postoperative assessment by clinical examination and 3D EAUS was performed at 2 weeks, 3 months and 6-12 months ("late control"). Long-term follow-up was carried out in 2017. The 3D EAUS examinations were blinded and analysed by two observers using a protocol with defined relevant findings for different follow-up time points., Results: A total of 95 patients with a total of 151 AFP procedures were included. Long-term follow-up was completed in 90 (95%) patients. Inflammation at 3 months, gas in fistula and visible fistula at 3 months and at late control, were statistically significant 3D EAUS findings for AFP failure. The combination of gas in fistula and clinical finding of fluid discharge through the external fistula opening 3 months postoperatively was statistically significant ( p < 0.001) for AFP failure with 91% sensitivity and 79% specificity. The positive predictive value was 91%, while the negative predictive value was 79%., Conclusions: 3D EAUS may be utilized for the follow-up of AFP treatment. Postoperative 3D EAUS at 3 months or later, especially if combined with clinical symptoms, can be used to predict long-term AFP failure. ClinicalTrials.gov identifier NCT03961984.
- Published
- 2023
- Full Text
- View/download PDF
43. Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort study.
- Author
-
Meijer LL, Vaalavuo Y, Regnér S, Sallinen V, Lemma A, Arnelo U, Valente R, Westermark S, An D, Moir JAG, Irwin EA, Biesel EA, Hopt UT, Fichtner-Feigl S, Wittel UA, Weniger M, Karle H, Bloemers FW, Sutton R, Charnley RM, Ruess DA, and Szatmary P
- Abstract
Background: Trauma to the pancreas is rare but associated with significant morbidity. Currently available management guidelines are based on low-quality evidence and data on long-term outcomes is lacking. This study aimed to evaluate clinical characteristics and patient-reported long-term outcomes for pancreatic injury., Methods: A retrospective cohort study evaluating treatment for pancreatic injury in 11 centers across 5 European nations over >10 years was performed. Data relating to pancreatic injury and treatment were collected from hospital records. Patients reported quality of life (QoL), changes to employment and new or ongoing therapy due to index injury., Results: In all, 165 patients were included. The majority were male (70.9%), median age was 27 years (range: 6-93) and mechanism of injury predominantly blunt (87.9%). A quarter of cases were treated conservatively; higher injury severity score (ISS) and American Association for the Surgery of Trauma (AAST) pancreatic injury scores increased the likelihood for surgical, endoscopic and/or radiologic intervention. Isolated, blunt pancreatic injury was associated with younger age and pancreatic duct involvement; this cohort appeared to benefit from non-operative management. In the long term (median follow-up 93; range 8-214 months), exocrine and endocrine pancreatic insufficiency were reported by 9.3% of respondents. Long-term analgesic use also affected 9.3% of respondents, with many reported quality of life problems (QoL) potentially attributable to side-effects of opiate therapy. Overall, impaired QoL correlated with higher ISS scores, surgical therapy and opioid analgesia on discharge., Conclusions: Pancreatic trauma is rare but can lead to substantial short- and long-term morbidity. Near complete recovery of QoL indicators and pancreatic function can occur despite significant injury, especially in isolated, blunt pancreatic injury managed conservatively and when early weaning off opiate analgesia is achieved., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
44. Fatty liver disease and pancreatic inflammation-A lethal combination?
- Author
-
Regnér S, Önnerhag K, and Sternby H
- Subjects
- Humans, Inflammation, Non-alcoholic Fatty Liver Disease diagnosis, Pancreatitis diagnosis, Pancreatitis etiology
- Published
- 2023
- Full Text
- View/download PDF
45. Is less more? Challenging dogma for individualized fluid resuscitation.
- Author
-
Regnér S
- Subjects
- Humans, Fluid Therapy
- Published
- 2023
- Full Text
- View/download PDF
46. Intussusception After Roux-en-Y Gastric Bypass: Correlation Between Radiological and Operative Findings.
- Author
-
Zaigham H, Ekelund M, Lee D, Ekberg O, and Regnér S
- Subjects
- Humans, Radiography, Hernia complications, Intussusception diagnostic imaging, Intussusception etiology, Intussusception surgery, Gastric Bypass adverse effects, Gastric Bypass methods, Obesity, Morbid surgery, Intestinal Obstruction diagnostic imaging, Intestinal Obstruction etiology, Intestinal Obstruction surgery, Laparoscopy adverse effects
- Abstract
Introduction: Intussusceptions diagnosed on computed tomography (CT) scans in Roux-en-Y gastric bypass (RYGB) patients could cause serious small bowel obstruction (SBO) or be an incidental finding. The objective of this study was to correlate radiological findings with clinical outcomes to differentiate intussusceptions requiring emergent surgery for SBO., Methods: A search for acute abdominal CT scans reporting intussusceptions in RYGB patients between 2012 and 2019 at Skåne University Hospital, Malmö, Sweden, retrieved 35 scans. These were independently reevaluated by two radiologists for the length and location of the intussusception, whether oral contrast passed through, proximal bowel dilatation, and signs of internal herniation. Clinical outcome in terms of emergency surgery and the diagnosis was determined through chart review., Results: Out of 35 acute patients, 9 patients required emergency surgery within 24 h. Intussusception caused SBO in five patients, and one patient had an internal herniation, while three patients had unremarkable findings. Eight patients were evaluated for intermittent pain with five unremarkable laparoscopies, while 18 patients had intussusceptions as incidental findings. Intussusception length on CT as measured by radiologists O.E. and D.L. predicted acute bowel obstruction (p = .014 and p < .001). A 100 mm threshold predicted bowel obstruction with a sensitivity of 80% and 100% and a specificity of 93% and 86% by radiologists O.E. and D.L., respectively. Proximal bowel dilatation predicted SBOs of any cause as well as SBO caused by an intussusception (all p < .05)., Conclusion: Intussusception length > 100 mm on CT in RYGB patients is an easy and valuable sign indicating SBO that may require emergent surgery., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
47. Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severity.
- Author
-
Luiken I, Eisenmann S, Garbe J, Sternby H, Verdonk RC, Dimova A, Ignatavicius P, Ilzarbe L, Koiva P, Penttilä AK, Regnér S, Dober J, Wohlgemuth WA, Brill R, Michl P, Rosendahl J, and Damm M
- Subjects
- Adult, Aged, Cohort Studies, Comorbidity, Disease Progression, Europe epidemiology, Female, Humans, Lung Diseases etiology, Lung Diseases pathology, Male, Middle Aged, Mortality, Pancreatitis complications, Pancreatitis pathology, Patient Acuity, Pleural Diseases diagnosis, Pleural Diseases etiology, Pleural Diseases pathology, Prevalence, Prognosis, Respiratory Insufficiency diagnosis, Respiratory Insufficiency epidemiology, Respiratory Insufficiency etiology, Retrospective Studies, Survival Analysis, Tomography, X-Ray Computed, Lung Diseases epidemiology, Pancreatitis diagnosis, Pancreatitis epidemiology, Pleural Diseases epidemiology
- Abstract
Background: Respiratory failure worsens the outcome of acute pancreatitis (AP) and underlying factors might be early detectable., Aims: To evaluate the prevalence and prognostic relevance of early pleuropulmonary pathologies and pre-existing chronic lung diseases (CLD) in AP patients., Methods: Multicentre retrospective cohort study. Caudal sections of the thorax derived from abdominal contrast enhanced computed tomography (CECT) performed in the early phase of AP were assessed. Independent predictors of severe AP were identified by binary logistic regression analysis. A one-year survival analysis using Kaplan-Meier curves and log rank test was performed., Results: 358 patients were analysed, finding pleuropulmonary pathologies in 81%. CECTs were performed with a median of 2 days (IQR 1-3) after admission. Multivariable analysis identified moderate to severe or bilateral pleural effusions (PEs) (OR = 4.16, 95%CI 2.05-8.45, p<0.001) and pre-existing CLD (OR = 2.93, 95%CI 1.17-7.32, p = 0.022) as independent predictors of severe AP. Log rank test showed a significantly worse one-year survival in patients with bilateral compared to unilateral PEs in a subgroup., Conclusions: Increasing awareness of the prognostic impact of large and bilateral PEs and pre-existing CLD could facilitate the identification of patients at high risk for severe AP in the early phase and thus improve their prognosis., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
48. The role of citrulline, intestinal fatty acid-binding protein, and D-dimer as potential biomarkers in the diagnosis of internal herniation after Roux-en-Y gastric bypass.
- Author
-
Zaigham H, Olsson Regnér Å, Ekelund M, and Regnér S
- Subjects
- Abdominal Pain etiology, Biomarkers blood, Citrulline blood, Fatty Acid-Binding Proteins blood, Fibrin Fibrinogen Degradation Products analysis, Humans, Laparoscopy, Postoperative Complications, Prospective Studies, Retrospective Studies, Abdominal Pain diagnosis, Gastric Bypass adverse effects, Obesity, Morbid surgery
- Abstract
Background: Diagnosing internal herniation (IH) in Roux-en-Y gastric bypass (RYGB) patients with acute abdominal pain poses a diagnostic challenge. Diagnostic laparoscopy is often required for a definitive diagnosis. We hypothesized that intestinal ischemia biomarkers would aid in the diagnosing of IH., Objectives: To explore intestinal ischemia biomarkers in diagnosing IH., Setting: University Hospital, Sweden., Methods: Prospective inclusion of 46 RYGB patients admitted for acute abdominal pain between June 2015 and December 2017. Blood samples for analysis of citrulline, intestinal fatty acid-binding protein (I-FABP), and D-dimer were drawn <72 hours from admission and compared between patients with IH (n = 8), small bowel obstruction (SBO) (n = 5), other specified diagnoses (n = 12), or unspecified abdominal pain (n = 21). Levels of white blood cell count (WBC), C-reactive protein (CRP), and lactate at admission were compared. A prospective pain questionnaire for time of pain onset and level of pain at onset and at admission was analyzed., Results: None of the investigated biomarkers differed significantly between diagnosis categories. Most patients with IH had normal CRP, WBC, and D-dimer levels while their lactate levels were significantly lower (P = .029) compared with the rest of the cohort. Neither pain level nor pain duration differed between the groups., Conclusion: This study shows that citrulline, I-FABP, and D-dimer cannot be used to diagnose IH and indicates that CRP, D-dimer, and lactate are rarely elevated by an IH. Furthermore, pain intensity and duration cannot differentiate patients with IH. A diagnostic laparoscopy remains the gold standard to diagnose and rule out an IH., (Copyright © 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
49. Heparin-binding protein is significantly increased in acute pancreatitis.
- Author
-
Sjöbeck M, Sternby H, Herwald H, Thorlacius H, and Regnér S
- Subjects
- Acute Disease, Antimicrobial Cationic Peptides, Blood Proteins, Carrier Proteins, Humans, Pancreatitis
- Abstract
Background: Most patients with acute pancreatitis (AP) experience mild, self-limiting disease with little or no need for hospital care. However, 20-25% of patients develop a more severe and potentially life-threatening condition with progressive systemic inflammatory response syndrome (SIRS) and multiorgan failure, resulting in high morbidity and mortality rates. Predicting disease severity at an early stage is important, as immediate supportive care has been demonstrated to reduce the incidence of SIRS and organ failure, improving patient outcome. Several studies have demonstrated elevated levels of heparin-binding protein (HBP) in patients with sepsis and septic shock, and HBP is believed to play a part in endothelial dysfunction leading to vascular leakage. As HBP levels increase prior to other known biomarkers, HBP has emerged as a promising early predictor of severe sepsis with organ dysfunction., Methods: Patients admitted to Skåne University Hospital in Malmö between 2010 and 2013 fulfilling the criteria for AP were identified in the emergency department and prospectively enrolled in this study. The primary outcome was measured levels of HBP upon hospital admission in patients with confirmed AP. Correlations among HBP concentrations, disease severity and fluid balance were considered secondary endpoints. The correlation between HBP levels and fluid balance were analysed using Pearson correlation, and the ability of HBP to predict moderately severe/severe AP was assessed using a receiver operating characteristic (ROC) curve., Results: The overall median HBP level in this study was 529 (307-898) ng/ml. There were no significant group differences in HBP levels based on AP severity. Fluid balance differed significantly between patients with mild versus moderately severe and severe pancreatitis, but we found no correlation between HBP concentration and fluid balance., Conclusions: HBP levels are dramatically increased in patients with AP, and these levels far exceed those previously reported in other conditions. In this study, we did not observe any significant correlation between HBP levels and disease severity or the need for intravenous fluid. Additional studies on HBP are needed to further explore the role of HBP in the pathogenesis of AP and its possible clinical implications., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
50. Differences in Health-Related Quality of Life After Gastric Bypass Surgery: a Cross-Sectional Study.
- Author
-
Antonsson T, Wennersten A, Sörensen K, Regnér S, and Ekelund M
- Subjects
- Cross-Sectional Studies, Humans, Quality of Life, Sweden epidemiology, Gastric Bypass, Obesity, Morbid surgery
- Abstract
Background: Gastric bypass (GBP) is a surgical method with good evidence of sustainable weight loss, reduced obesity-related comorbidities, and improved health-related quality of life (HRQoL). However, long-term data post-GBP is scarce on HRQoL related to other factors than weight loss, such as impact of socio-economic, age, and gender., Aim: To investigate long-term HRQoL in GBP patients., Methods: The study was conducted as a cross-sectional study covering 3 to 9 years post-GBP measuring HRQoL using RAND-36. Association to weight loss, time since surgery, gender, educational level, occupation, and age was analyzed. The participants were included on the basis that they had received a GBP that was performed by Region Skåne, the southernmost administrative healthcare region in Sweden. Recruitment to the study was by mail invitation for an online survey., Results: Of the total population of 5310 persons receiving the questionnaire, 1339 of the 1372 responders fulfilled the inclusion criteria. Those with low educational level, unemployed, persons on sick leave or disability support, and those with less weight loss reported the lowest HRQoL. The longer time since surgery, the lower the HRQoL., Conclusion: Less weight loss, longer time since GBP, lower educational level, and lower degree of employment all affect HRQoL negatively after GBP surgery.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.